Cargando…

Cell-Mediated Immune Responses to COVID-19 Infection

An unprecedented outbreak of pneumonia caused by a novel coronavirus (CoV), subsequently termed COVID-19 by the World Health Organization, emerged in Wuhan City (China) in December 2019. Despite rigorous containment and quarantine efforts, the incidence of COVID-19 continues to expand, causing explo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guihot, Amélie, Litvinova, Elena, Autran, Brigitte, Debré, Patrice, Vieillard, Vincent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350607/ https://www.ncbi.nlm.nih.gov/pubmed/32719687 http://dx.doi.org/10.3389/fimmu.2020.01662

Ejemplares similares

Memory CD4+ T-Cell Lymphocytic Angiopathy in Fatal Forms of COVID-19 Pulmonary Infection
por: Guihot, Amélie, et al.
Publicado: (2022)

HIV-specific T Cell Cytotoxicity Mediated by RANTES Via the Chemokine Receptor CCR3
por: Hadida, Fabienne, et al.
Publicado: (1998)

Skewed T cell responses to Epstein-Barr virus in long-term asymptomatic kidney transplant recipients
por: Nakid-Cordero, Cecilia, et al.
Publicado: (2019)

Neutralizing Antibodies Against a Specific Human Immunodeficiency Virus gp41 Epitope are Associated With Long-term Non-progressor Status
por: Lucar, Olivier, et al.
Publicado: (2017)

Natural Killer Cells in Post-Transplant Lymphoproliferative Disorders
por: Nakid-Cordero, Cecilia, et al.
Publicado: (2021)

NKp44L: A new tool for fighting cancer
por: Vieillard, Vincent, et al.
Publicado: (2014)

Perspectives for immunotherapy: which applications might achieve an HIV functional cure?
por: Vieillard, Vincent, et al.
Publicado: (2016)

Anti-PD-1 immune-related adverse events are associated with high therapeutic antibody fixation on T cells
por: Gazzano, Marianne, et al.
Publicado: (2022)

NK Cell Terminal Differentiation: Correlated Stepwise Decrease of NKG2A and Acquisition of KIRs
por: Béziat, Vivien, et al.
Publicado: (2010)

Comparative impact of antiretroviral drugs on markers of inflammation and immune activation during the first two years of effective therapy for HIV-1 infection: an observational study
por: Hattab, Suhaib, et al.
Publicado: (2014)

Unconventional Repertoire Profile Is Imprinted during Acute Chikungunya Infection for Natural Killer Cells Polarization toward Cytotoxicity
por: Petitdemange, Caroline, et al.
Publicado: (2011)

HIV gp41 Engages gC1qR on CD4+ T Cells to Induce the Expression of an NK Ligand through the PIP3/H2O2 Pathway
por: Fausther-Bovendo, Hugues, et al.
Publicado: (2010)

Transplantation-induced cancers: Emerging evidence that clonal CMV-specific NK cells are causal immunogenic factors
por: Achour, Abla, et al.
Publicado: (2014)

Dichotomy in Neutralizing Antibody Induction to Peptide-Conjugated Vaccine in Squalene Emulsion Contrast With Aluminum Hydroxide Formulation
por: Bonduelle, Olivia, et al.
Publicado: (2022)

Distinct Time Effects of Vaccination on Long-Term Proliferative and IFN-γ–producing T Cell Memory to Smallpox in Humans
por: Combadiere, Behazine, et al.
Publicado: (2004)

Human ACE2 peptide-mimics block SARS-CoV-2 pulmonary cells infection
por: Karoyan, Philippe, et al.
Publicado: (2021)

The Modulation of the Cell-Cycle: A Sentinel to Alert the NK Cells of Dangers
por: Baychelier, Florence, et al.
Publicado: (2013)

Longitudinal Analysis of Natural Killer Cells in Dengue Virus-Infected Patients in Comparison to Chikungunya and Chikungunya/Dengue Virus-Infected Patients
por: Petitdemange, Caroline, et al.
Publicado: (2016)

P19-25. A vaccine model to prevent the depletion of uninfected bystander CD4 cells during HIV infection
por: Vieillard, V, et al.
Publicado: (2009)

The Hard Way towards an Antibody-Based HIV-1 Env Vaccine: Lessons from Other Viruses
por: Ringel, Oliver, et al.
Publicado: (2018)

Control of Acute Dengue Virus Infection by Natural Killer Cells
por: Petitdemange, Caroline, et al.
Publicado: (2014)

HLA-C-restricted viral epitopes are associated with an escape mechanism from KIR2DL2(+) NK cells in Lassa virus infection
por: Wauquier, Nadia, et al.
Publicado: (2019)

Identification of natural killer markers associated with fatal outcome in COVID-19 patients
por: Tarantino, Nadine, et al.
Publicado: (2023)

CAR T-cell therapy for central nervous system lymphomas: blood and cerebrospinal fluid biology, and outcomes
por: Lacan, Claire, et al.
Publicado: (2023)

Accumulation of Intrahepatic TNF-α-Producing NKp44(+) NK Cells Correlates With Liver Fibrosis and Viral Load in Chronic HCV Infection
por: Nel, Isabelle, et al.
Publicado: (2016)

NK Cells in the Human Lungs
por: Hervier, Baptiste, et al.
Publicado: (2019)

Editorial: NK Cells in Human Diseases: Friends or Foes?
por: Vieillard, Vincent, et al.
Publicado: (2017)

Cell-Mediated Immune Responses and Immunopathogenesis of Human Tick-Borne Encephalitis Virus-Infection
por: Blom, Kim, et al.
Publicado: (2018)

The Immune Response and Immunopathology of COVID-19
por: Mortaz, Esmaeil, et al.
Publicado: (2020)

γδ T Cell-Mediated Immunity to Cytomegalovirus Infection
por: Khairallah, Camille, et al.
Publicado: (2017)

Cellular Immune Response to COVID-19 and Potential Immune Modulators
por: Zhou, Xi, et al.
Publicado: (2021)

Toll-like receptor-mediated innate immunity orchestrates adaptive immune responses in HBV infection
por: Du, Yanqin, et al.
Publicado: (2022)

LOX-1-Expressing Immature Neutrophils Identify Critically-Ill COVID-19 Patients at Risk of Thrombotic Complications
por: Combadière, Behazine, et al.
Publicado: (2021)

Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose
por: Belik, Milja, et al.
Publicado: (2023)

COVID-19 outcomes in patients with a history of immune-mediated glomerular diseases
por: Gauckler, Philipp, et al.
Publicado: (2023)

HLA, Immune Response, and Susceptibility to COVID-19
por: Tavasolian, Fataneh, et al.
Publicado: (2021)

Immune Response to COVID-19 During Pregnancy
por: Chen, Ge, et al.
Publicado: (2021)

γδ T Cell-Mediated Immune Responses in Disease and Therapy
por: Latha, T. Sree, et al.
Publicado: (2014)

T Cell-Mediated Immune Responses to AAV and AAV Vectors
por: Ertl, Hildegund C. J.
Publicado: (2021)

Immune Response in Moderate to Critical Breakthrough COVID-19 Infection After mRNA Vaccination
por: Paniskaki, Krystallenia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1cjv9i5qcm09r9hr74k6rjqsjs